Entheon Biomedical Corp. (CNSX: ENBI.X)
Health Care · Biotechnology · CA
CA$—
— today · — 1Y
Entheon Biomedical Corp. (CNSX: ENBI.X) operates in the Biotechnology industry within the Health Care sector. The company is valued at $590.46K and employs 1 people.
trading between 0.05 and 0.13.
Tweenvest scores Entheon Biomedical Corp. across four factors: quality 28/100. Its strongest factor is quality.
ENBI.X price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $590.46K
- Revenue (TTM)
- —
- P/E
- 19.18
- EPS
- 0.00
- Dividend yield
- —
- Beta (5Y)
- 1.51
- 52-week high
- CA$0.13
- 52-week low
- CA$0.05
- Avg volume (3M)
- —
- Shares outstanding
- 13.86M
- Employees
- 1
- Next earnings
- —
About Entheon Biomedical Corp.
Entheon Biomedical Corp. operates as a biotechnology research and drug development company. It engages in developing and commercializing various N,N-dimethyltryptamine based psychedelic therapeutic products for treating addiction and substance use disorders. The company serves physicians, clinics, and licensed psychiatrists in Canada, the United States, and European Union. Entheon Biomedical Corp. is headquartered in Vancouver, Canada.
- Listed since
- May 3, 2018
- Exchange
- Canadian National Stock Exchange
- Currency
- CAD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $468.22B | $264.96 | +1.20% |
| Amgen Inc.NasdaqGS: AMGN | $237.52B | $439.33 | +1.29% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.18B | $146.12 | +1.86% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.91B | $548.05 | +1.44% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.28B | $834.04 | +0.90% |
| argenx SEENXTBR: ARGX | $65.85B | €902.00 | +1.90% |
| Moderna, Inc.NasdaqGS: MRNA | $57.92B | $145.13 | +0.04% |
| CSL LimitedASX: CSL | $57.77B | AU$168.30 | -1.69% |
Figures last refreshed Aug 18, 2026.